Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Diseases
1.3.3 Neurology
1.3.4 Cardiovascular
1.3.5 Lifestyle and Endocrinology
1.3.6 Gastroenterology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Oncology Precision Medicine Market Perspective (2017-2028)
2.2 Non-Oncology Precision Medicine Growth Trends by Region
2.2.1 Non-Oncology Precision Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-Oncology Precision Medicine Historic Market Size by Region (2017-2022)
2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Region (2023-2028)
2.3 Non-Oncology Precision Medicine Market Dynamics
2.3.1 Non-Oncology Precision Medicine Industry Trends
2.3.2 Non-Oncology Precision Medicine Market Drivers
2.3.3 Non-Oncology Precision Medicine Market Challenges
2.3.4 Non-Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Non-Oncology Precision Medicine Players by Revenue (2017-2022)
3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue
3.4 Global Non-Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Oncology Precision Medicine Revenue in 2021
3.5 Non-Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Non-Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Non-Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Oncology Precision Medicine Breakdown Data by Type
4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2017-2022)
4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2023-2028)
5 Non-Oncology Precision Medicine Breakdown Data by Application
5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2017-2022)
5.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Oncology Precision Medicine Market Size (2017-2028)
6.2 North America Non-Oncology Precision Medicine Market Size by Type
6.2.1 North America Non-Oncology Precision Medicine Market Size by Type (2017-2022)
6.2.2 North America Non-Oncology Precision Medicine Market Size by Type (2023-2028)
6.2.3 North America Non-Oncology Precision Medicine Market Share by Type (2017-2028)
6.3 North America Non-Oncology Precision Medicine Market Size by Application
6.3.1 North America Non-Oncology Precision Medicine Market Size by Application (2017-2022)
6.3.2 North America Non-Oncology Precision Medicine Market Size by Application (2023-2028)
6.3.3 North America Non-Oncology Precision Medicine Market Share by Application (2017-2028)
6.4 North America Non-Oncology Precision Medicine Market Size by Country
6.4.1 North America Non-Oncology Precision Medicine Market Size by Country (2017-2022)
6.4.2 North America Non-Oncology Precision Medicine Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Oncology Precision Medicine Market Size (2017-2028)
7.2 Europe Non-Oncology Precision Medicine Market Size by Type
7.2.1 Europe Non-Oncology Precision Medicine Market Size by Type (2017-2022)
7.2.2 Europe Non-Oncology Precision Medicine Market Size by Type (2023-2028)
7.2.3 Europe Non-Oncology Precision Medicine Market Share by Type (2017-2028)
7.3 Europe Non-Oncology Precision Medicine Market Size by Application
7.3.1 Europe Non-Oncology Precision Medicine Market Size by Application (2017-2022)
7.3.2 Europe Non-Oncology Precision Medicine Market Size by Application (2023-2028)
7.3.3 Europe Non-Oncology Precision Medicine Market Share by Application (2017-2028)
7.4 Europe Non-Oncology Precision Medicine Market Size by Country
7.4.1 Europe Non-Oncology Precision Medicine Market Size by Country (2017-2022)
7.4.2 Europe Non-Oncology Precision Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2017-2028)
8.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type
8.2.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-Oncology Precision Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application
8.3.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-Oncology Precision Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region
8.4.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Oncology Precision Medicine Market Size (2017-2028)
9.2 Latin America Non-Oncology Precision Medicine Market Size by Type
9.2.1 Latin America Non-Oncology Precision Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Non-Oncology Precision Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Non-Oncology Precision Medicine Market Share by Type (2017-2028)
9.3 Latin America Non-Oncology Precision Medicine Market Size by Application
9.3.1 Latin America Non-Oncology Precision Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Non-Oncology Precision Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Non-Oncology Precision Medicine Market Share by Application (2017-2028)
9.4 Latin America Non-Oncology Precision Medicine Market Size by Country
9.4.1 Latin America Non-Oncology Precision Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Non-Oncology Precision Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2017-2028)
10.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type
10.2.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-Oncology Precision Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application
10.3.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-Oncology Precision Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country
10.4.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.2.5 Agilent Technologies, Inc. Recent Developments
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Details
11.3.2 Asuragen, Inc. Business Overview
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction
11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.3.5 Asuragen, Inc. Recent Developments
11.4 Almac Group
11.4.1 Almac Group Company Details
11.4.2 Almac Group Business Overview
11.4.3 Almac Group Non-Oncology Precision Medicine Introduction
11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.4.5 Almac Group Recent Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Details
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction
11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.5.5 AstraZeneca PLC Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction
11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 bioM?rieux SA.
11.7.1 bioM?rieux SA. Company Details
11.7.2 bioM?rieux SA. Business Overview
11.7.3 bioM?rieux SA. Non-Oncology Precision Medicine Introduction
11.7.4 bioM?rieux SA. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.7.5 bioM?rieux SA. Recent Developments
11.8 BGI
11.8.1 BGI Company Details
11.8.2 BGI Business Overview
11.8.3 BGI Non-Oncology Precision Medicine Introduction
11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.8.5 BGI Recent Developments
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Details
11.9.2 Danaher Corp. Business Overview
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction
11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.9.5 Danaher Corp. Recent Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction
11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.10.5 Illumina, Inc. Recent Developments
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Details
11.11.2 Invitae Corporation Business Overview
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction
11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.11.5 Invitae Corporation Recent Developments
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Details
11.12.2 Opko Health, Inc. Business Overview
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction
11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.12.5 Opko Health, Inc. Recent Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer